Use and misuse of composite endpoints in randomised clinical trials.

Composite endpoints are widely used in large randomised cardiovascular outcome trials. They are frequently referred to as major adverse cardiovascular event (MACE), although there is no consensus around this definition. In essence, composite endpoint…

Preview only. Read the full abstract at the source